Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Sundar Jagannath, MD, Mount Sinai
Videos
Bispecific Antibodies, CAR T-Cell Therapy, and BCMA-Directed Therapy for the Treatment of Multiple Myeloma With Curative Intent
02/23/2023
Sundar Jagannath, MD, provides an update on how immunotherapy and cellular therapy are changing treatment approaches for multiple myeloma.
Sundar Jagannath, MD, provides an update on how immunotherapy and cellular therapy are changing treatment approaches for multiple myeloma.
Sundar Jagannath, MD, provides...
02/23/2023
Oncology
Gail Roboz, MD, Weill Cornell Medicine
Videos
How to Handle Challenging Management Issues in AML
02/23/2023
Gail J. Roboz, MD, provides some key points to consider when handling challenging management issues in AML at the 2022 Lymphoma, Leukemia & Myeloma Congress in New York.
Gail J. Roboz, MD, provides some key points to consider when handling challenging management issues in AML at the 2022 Lymphoma, Leukemia & Myeloma Congress in New York.
Gail J. Roboz, MD, provides some...
02/23/2023
Oncology
Dan Vogl, MD, University of Pennsylvania
Videos
Bispecific T-Cell Engagers and Novel Approaches for the Treatment of Multiple Myeloma
02/23/2023
Dan Vogl, MD discusses options for bispecific T-Cell engagers when treating patients with multiple myeloma.
Dan Vogl, MD discusses options for bispecific T-Cell engagers when treating patients with multiple myeloma.
Dan Vogl, MD discusses options...
02/23/2023
Oncology
Faith Davies, MD
Videos
What Is the Optimal Combination for Patients With Multiple Myeloma in Early Relapse?
02/16/2023
Faith E. Davies, MD, provides an update on treatment options for patients with multiple myeloma in early relapse at the 2022 Lymphoma, Leukemia & Myeloma Congress in New York.
Faith E. Davies, MD, provides an update on treatment options for patients with multiple myeloma in early relapse at the 2022 Lymphoma, Leukemia & Myeloma Congress in New York.
Faith E. Davies, MD, provides an...
02/16/2023
Oncology
Pinkal Desai, MD
Videos
What Every Doctor Should Know About Clonal Hematopoiesis
02/15/2023
Pinkal Desai, MD, provides the latest updates on clonal hematopoiesis, highlighting what doctors should know about these aging-associated mutations.
Pinkal Desai, MD, provides the latest updates on clonal hematopoiesis, highlighting what doctors should know about these aging-associated mutations.
Pinkal Desai, MD, provides the...
02/15/2023
Oncology
Shaji Kumar, MD
Videos
Strategies for Treating Frail and Transplant-Ineligible Patients With Multiple Myeloma
01/26/2023
Shaji Kumar, MD, provides insight into approaches for treating frail and transplant-ineligible patients with multiple myeloma.
Shaji Kumar, MD, provides insight into approaches for treating frail and transplant-ineligible patients with multiple myeloma.
Shaji Kumar, MD, provides...
01/26/2023
Oncology
Javid Moslehi, MD
Videos
Considerations for Cardiovascular Adverse Events Associated With BTK Inhibitors for Patients With CLL
12/06/2022
Javid Moslehi, MD, discusses the cardiovascular risks associated with utilization of BTK inhibitors for patients with CLL and outlines best practices for managing these adverse events.
Javid Moslehi, MD, discusses the cardiovascular risks associated with utilization of BTK inhibitors for patients with CLL and outlines best practices for managing these adverse events.
Javid Moslehi, MD, discusses the...
12/06/2022
Oncology
Jia Ruan, MD
Videos
Novel Agents for Treatment of Patients With T-Cell Non-Hodgkin Lymphoma
12/01/2022
Jia Ruan, MD, highlights recent advancements in the treatment of patients with T-Cell non-Hodgkin lymphoma, presenting updated information on novel agents and ongoing clinical trials in this space.
Jia Ruan, MD, highlights recent advancements in the treatment of patients with T-Cell non-Hodgkin lymphoma, presenting updated information on novel agents and ongoing clinical trials in this space.
Jia Ruan, MD, highlights recent...
12/01/2022
Oncology
Julie Vose, MD
Videos
Approaches to Initial Therapy for Patients With Aggressive DLBCL
11/22/2022
Julie Vose, MD, provides insight into the latest approaches to initial therapy for patients with aggressive diffuse large B-cell lymphoma at the 2022 Lymphoma, Leukemia & Myeloma Congress in New York.
Julie Vose, MD, provides insight into the latest approaches to initial therapy for patients with aggressive diffuse large B-cell lymphoma at the 2022 Lymphoma, Leukemia & Myeloma Congress in New York.
Julie Vose, MD, provides insight...
11/22/2022
Oncology
Othman Al-Sawaf, MD
Videos
Role of Minimal Residual Disease in the Management of CLL: How Do We Use it and When?
11/15/2022
Othman Al-Sawaf, MD, provides insight into the best use of minimal residual disease in the management of patients with CLL, which he presented at the 2022 Lymphoma, Leukemia & Myeloma Congress.
Othman Al-Sawaf, MD, provides insight into the best use of minimal residual disease in the management of patients with CLL, which he presented at the 2022 Lymphoma, Leukemia & Myeloma Congress.
Othman Al-Sawaf, MD, provides...
11/15/2022
Oncology

Advertisement

Advertisement

About

For nearly 2 decades, the Lymphoma, Leukemia & Myeloma Congress (formerly the Lymphoma & Myeloma Congress) has been recognized around the world as the most respected forum for industry-leading hematologic research.

It’s where interdisciplinary specialists convene to explore the controversial and the complex, the emerging and the exciting, and discuss, debate, and discover along the way.

This program features 4 days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders.

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use